Insights into the Role of Fc Gamma Receptors (Fc&ggr;Rs) Genetic Variations in Monoclonal Antibody-Based Anti-Cancer Therapy

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 5, Iss. 3, 2010-11 ,pp. : 197-204

Bentham Science Publishers

Access to resources Recommend Favorite

Cost Considerations for Monoclonal Antibody-Targeted Therapy in Cancer: Focus on Trastuzumab

By Neyt Mattias  

American Journal of Cancer, Vol. 5, Iss. 1, 2006-01 ,pp. : 19-26

Adis International

Access to resources Recommend Favorite

CD44v6: a target for antibody-based cancer therapy

By Heider Karl-Heinz   Kuthan Hartmut   Stehle Gerd   Munzert Gerd  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 7, 2004-07 ,pp. : 567-579

Springer Publishing Company

Access to resources Recommend Favorite

Ten-year follow-up of a prospective trial for the targeted therapy of gastric cancer with the human monoclonal antibody PAT-SC1

By            

Oncology Reports, Vol. 31, Iss. 3, 2014-01 ,pp. : 1059-1066

Spandidos Publications

Access to resources Recommend Favorite

Preclinical Therapy of Breast Cancer with a Radioiodinated Humanized Anti-EGP-1 Monoclonal Antibody: Advantage of a Residualizing Iodine Radiolabel

By Govindan Serengulam V.   Stein Rhona   Qu Zhengxing   Chen Susan   Andrews Philip   Ma Hong   Hansen Hans J.   Griffiths Gary L.   Horak Ivan D.   Goldenberg David M.  

Breast Cancer Research and Treatment, Vol. 84, Iss. 2, 2004-03 ,pp. : 173-182

Springer Publishing Company

Access to resources Recommend Favorite